NEW YORK – The European Commission on Monday approved Johnson & Johnson's subcutaneous Rybrevant (amivantamab) in two new dosing schedules as a first-line treatment for patients with advanced ...
Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with ...
Knee pain can take a toll by interfering with work, leisure and daily activities. Knee injections can help manage the pain and other symptoms such as stiffness and limited movement. Knee injections ...
The World Anti-Doping Agency is investigating whether ski jumpers were injecting their penises with hyaluronic acid in order to fly further In the quest for Olympic gold, professional athletes endure ...
Billions of dollars in U.S. biosimilar erosion to AbbVie’s blockbuster immunology drug Humira is no match for its rising superstar Skyrizi. Despite the fall of what was once the world’s top-selling ...
Attorney General Pam Bondi’s demand that Minnesota hand over sensitive voter registration records to the federal government amid tensions over ICE and immigration enforcement underscores the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results